GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Amylin Pharmaceuticals, Inc. (AMLN) [hlAlert]

Rating:
Buy AMLN
down 37.85 %

Amylin Pharmaceuticals, Inc. (AMLN) rated Buy

Posted on: Monday,  Aug 27, 2007  9:25 AM ET by CIBC Wrld Mkts

CIBC Wrld Mkts rated Buy Amylin Pharmaceuticals, Inc. (NASDAQ: AMLN) on 08/27/2007, when the stock price was $49.79.
Since then, Amylin Pharmaceuticals, Inc. has lost 37.86% as of 08/06/2012's recent price of $30.94.
If you would have followed this CIBC Wrld Mkts's recommendation on AMLN, you would have lost 37.85% of your investment in 1806 days.

Amylin Pharmaceuticals is a biopharmaceutical company committed to improving lives through the discovery, development and commercialization of innovative medicines. Amylin has developed and gained approval for two first-in-class medicines for diabetes, SYMLIN injection and BYETTA injection. Amylin's research and development activities leverage the company's expertise in metabolism to develop potential therapies to treat diabetes and obesity. Amylin is located in San Diego, California with over one thousand five hundred employees nationwide.

CIBC World Markets strives to deliver leading edge investment research to investing clients through our multi-faceted, firm-wide research product offering. Our research has consistently been recognized as a top research source for its breadth of coverage, industry knowledge and quality of work in generating profitable and timely investment ideas. We provide in-depth coverage for all of the major sectors of the Canadian economy and select coverage of U.S. companies. Our analytical teams remain committed to identifying trends early and developing exploitable investment opportunities across the market capitalization spectrum. With the continued growth in quantitative and computerized investing strategies, we have also developed leading edge quantitative and technical research products to partner with our fundamental approach. Our products are available through several automated avenues: email, website, and third-party market vendors. Client service is our driving force and we constantly advance in offering greater product customization options.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
8/27/2007 9:25 AM Buy
None
49.79 58.00
as of 8/27/2015
1 Week   
1 Month   
3 Months   
1 YTD up  15.96 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy